The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
Open accessAbstract
The purpose of our study was to determine the relationship between mutant huntingtin (Htt) and mitochondrial dynamics in the progression of Huntington's disease (HD). We measured the mRNA levels of electron transport chain genes, and mitochondrial structural genes, Drp1 (dynamin-related protein 1), Fis1 (fission 1), Mfn1 (mitofusin 1), Mfn2 (mitofusin 2), Opa1 (optric atrophy 1), Tomm40 (translocase of outermembrane 40) and CypD (cyclophilin D) in grade III and grade IV HD patients and controls. The mutant Htt oligomers and the mitochondrial structural proteins were quantified in the striatum and frontal cortex of HD patients. Changes in expressions of the electron transport chain genes were found in HD patients and may represent a compensatory response to mitochondrial damage caused by mutant Htt. Increased expression of Drp1 and Fis1 and decreased expression of Mfn1, Mfn2, Opa1 and Tomm40 were found in HD patients relative to the controls. CypD was upregulated in HD patients, and this upregulation increased as HD progressed. Significantly increased immunoreactivity of 8-hydroxy-guanosine was found in the cortical specimens from stage III and IV HD patients relative to controls, suggesting increased oxidative DNA damage in HD patients. In contrast, significantly decreased immunoreactivities of cytochrome oxidase 1 and cytochrome b were found in HD patients relative to controls, indicating a loss of mitochondrial function in HD patients. Immunoblotting analysis revealed 15, 25 and 50 kDa mutant Htt oligomers in the brain specimens of HD patients. All oligomeric forms of mutant Htt were significantly increased in the cortical tissues of HD patients, and mutant Htt oligomers were found in the nucleus and in mitochondria. The increase in Drp1, Fis1 and CypD and the decrease in Mfn1 and Mfn2 may be responsible for abnormal mitochondrial dynamics that we found in the cortex of HD patients, and may contribute to neuronal damage in HD patients. The presence of mutant Htt oligomers in the nucleus of HD neurons and in mitochondria may disrupt neuronal functions. Based on these findings, we propose that mutant Htt in association with mitochondria imbalance and mitochondrial dynamics impairs axonal transport of mitochondria, decreases mitochondrial function and damages neurons in affected brain regions of HD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Trinucleotide Repeat Disorders
Orr, H. T., & Zoghbi, H. Y. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113042 · Cited by 1,368
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-09.2009 · Cited by 1,224
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Self-citationEarly mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Reddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975
Dagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Du, H., Guo, L., Fang, F., Chen, D., A Sosunov, A., M McKhann, G., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 932
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
The PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885
Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835
Deng, H., Dodson, M. W., Huang, H., & Guo, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803998105 · Cited by 689
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
Trushina, E., Dyer, R. B., Badger, J. D., Ure, D., Eide, L., Tran, D. D., Vrieze, B. T., Legendre-Guillemin, V., McPherson, P. S., Mandavilli, B. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8195-8209.2004 · Cited by 520
Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515
Oxidative stress in Huntington’s disease
Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508
Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons
Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P., Szeto, H. H., Park, B., & Reddy, P. H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100564 · Cited by 469
Self-citationThakur, A. K., Jayaraman, M., Mishra, R., Thakur, M., Chellgren, V. M., L Byeon, I.-J., Anjum, D. H., Kodali, R., Creamer, T. P., Conway, J. F., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1570 · Cited by 437
N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking
Orr, A. L., Li, S., Wang, C.-E., Li, H., Wang, J., Rong, J., Xu, X., Mastroberardino, P. G., Greenamyre, J. T., & Li, X.-J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0106-08.2008 · Cited by 430
Atwal, R. S., Xia, J., Pinchev, D., Taylor, J., Epand, R. M., & Truant, R. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm217 · Cited by 387
Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, E. J., Riege, W. H., & Winter, J. (1982) · Annals of Neurology · doi:10.1002/ana.410120504 · Cited by 376
Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation
Lutz, A. K., Exner, N., Fett, M. E., Schlehe, J. S., Kloos, K., Lämmermann, K., Brunner, B., Kurz-Drexler, A., Vogel, F., Reichert, A. S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035774 · Cited by 373
Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization
Poirier, M. A., Li, H., Macosko, J., Cai, S., Amzel, M., & Ross, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205809200 · Cited by 367
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease
Kim, J., Moody, J. P., Edgerly, C. K., Bordiuk, O. L., Cormier, K., Smith, K., Beal, M. F., & Ferrante, R. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq306 · Cited by 357
Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons
Chang, D. T. W., Rintoul, G. L., Pandipati, S., & Reynolds, I. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.007 · Cited by 299
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., Gusella, J. F., Laramie, J. M., Myers, R. H., Lesort, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi319 · Cited by 294
Costa, V., Giacomello, M., Hudec, R., Lopreiato, R., Ermak, G., Lim, D., Malorni, W., Davies, K. J. A., Carafoli, E., & Scorrano, L. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000102 · Cited by 288
Kegel, K. B., Meloni, A. R., Yi, Y., Kim, Y. J., Doyle, E., Cuiffo, B. G., Sapp, E., Wang, Y., Qin, Z.-H., Chen, J. D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103946200 · Cited by 287
Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M., & Muchowski, P. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb860 · Cited by 283
Progression of Symptoms in the Early and Middle Stages of Huntington Disease
Kirkwood, S. C., Su, J. L., Conneally, P. M., & Foroud, T. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.273 · Cited by 269
Brain imaging and cognitive dysfunctions in Huntington’s disease
Montoya, A., Price, B. H., Menear, M., & Lepage, M. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0603 · Cited by 265
Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease
Reddy, P. H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.042 · Cited by 264
Weight loss in Huntington disease increases with higher CAG repeat number
Aziz, N. A., van der Burg, J. M. M., Landwehrmeyer, G. B., Brundin, P., Stijnen, T., EHDI Study Group, & Roos, R. A. C. (2008) · Neurology · doi:10.1212/01.wnl.0000334276.09729.0e · Cited by 261
Legleiter, J., Mitchell, E., Lotz, G. P., Sapp, E., Ng, C., DiFiglia, M., Thompson, L. M., & Muchowski, P. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093708 · Cited by 235
Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers
Kostka, M., Högen, T., Danzer, K. M., Levin, J., Habeck, M., Wirth, A., Wagner, R., Glabe, C. G., Finger, S., Heinzelmann, U., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709634200 · Cited by 226
Effects of overexpression of Huntingtin proteins on mitochondrial integrity
Wang, H., Lim, P. J., Karbowski, M., & Monteiro, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn404 · Cited by 224
Young, A. B., Penney, J. B., Starosta‐Rubinstein, S., Markel, D. S., Berent, S., Giordani, B., Ehrenkaufer, R., Jewett, D., & Hichwa, R. (1986) · Annals of Neurology · doi:10.1002/ana.410200305 · Cited by 218
CORTICAL AND SUBCORTICAL GLUCOSE CONSUMPTION MEASURED BY PET IN PATIENTS WITH HUNTINGTON'S DISEASE
KUWERT, T., LANGE, H. W., LANGEN, K.-J., HERZOG, H., AULICH, A., & FEINENDEGEN, L. E. (1990) · Brain · doi:10.1093/brain/113.5.1405 · Cited by 217
Longitudinal change in basal ganglia volume in patients with Huntington's disease
Aylward, E. H., Li, Q., Stine, O. C., Ranen, N., Sherr, M., Barta, P. E., Bylsma, F. W., Pearlson, G. D., & Ross, C. A. (1997) · Neurology · doi:10.1212/wnl.48.2.394 · Cited by 217
Recent advances in understanding the pathogenesis of Huntington's disease
Reddy, P. H., Williams, M., & Tagle, D. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01415-0 · Cited by 200
Self-citationCerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases
Jernigan, T. L., Salmon, D. P., Butters, N., & Hesselink, J. R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90211-4 · Cited by 198
The molecular genetics of Huntington disease — a history
Bates, G. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1686 · Cited by 193
Ko, J., Ou, S., & Patterson, P. H. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00599-8 · Cited by 191
Samochowiec, J., Lesch, K.-P., Rottmann, M., Smolka, M., Syagailo, Y. V., Okladnova, O., Rommelspacher, H., Winterer, G., Schmidt, L. G., & Sander, T. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00020-7 · Cited by 190
Mitochondrial Dysfunction in Aging and Alzheimer's Disease: Strategies to Protect Neurons
Reddy, P. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1754 · Cited by 186
Huntington’s disease: Clinical correlates of disability and progression
Mahant, N., McCusker, E. A., Byth, K., Graham, S., & The Huntington Study Group (2003) · Neurology · doi:10.1212/01.wnl.0000086373.32347.16 · Cited by 178
Selective defect of in vivo glycolysis in early Huntington's disease striatum
Powers, W. J., Videen, T. O., Markham, J., McGee-Minnich, L., Antenor-Dorsey, J. V., Hershey, T., & Perlmutter, J. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609833104 · Cited by 174
Huntingtin Associates with Acidic Phospholipids at the Plasma Membrane
Kegel, K. B., Sapp, E., Yoder, J., Cuiffo, B., Sobin, L., Kim, Y. J., Qin, Z.-H., Hayden, M. R., Aronin, N., Scott, D. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503672200 · Cited by 173
Berent, S., Giordani, B., Lehtinen, S., Markel, D., Penney, J. B., Buchtel, H. A., Starosta‐Rubinstein, S., Hichwa, R., & Young, A. B. (1988) · Annals of Neurology · doi:10.1002/ana.410230603 · Cited by 171
Frontal lobe volume in patients with Huntington's disease
Aylward, E. H., Anderson, N. B., Bylsma, F. W., Wagster, M. V., Barta, P. E., Sherr, M., Feeney, J., Davis, A., Rosenblatt, A., Pearlson, G. D., et al. (1998) · Neurology · doi:10.1212/wnl.50.1.252 · Cited by 171
Aylward, E. H., Brandt, J., Codori, A. M., Mangus, R. S., Barta, P. E., & Harris, G. J. (1994) · Neurology · doi:10.1212/wnl.44.5.823 · Cited by 168
Sathasivam, K., Lane, A., Legleiter, J., Warley, A., Woodman, B., Finkbeiner, S., Paganetti, P., Muchowski, P. J., Wilson, S., & Bates, G. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp467 · Cited by 167
Mitochondrial structural and functional dynamics in Huntington's disease
Reddy, P. H., Mao, P., & Manczak, M. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.04.001 · Cited by 161
Self-citationPositron emission tomography in the early diagnosis of Huntington's disease
Hayden, M. R., Martin, W. R. W., Stoessl, A. J., Clark, C., Hollenberg, S., Adam, M. J., Ammann, W., Harrop, R., Rogers, J., Ruth, T., et al. (1986) · Neurology · doi:10.1212/wnl.36.7.888 · Cited by 159
Gutala, R. V., & Reddy, P. H. (2003) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.09.005 · Cited by 129
Clinical‐pathologic correlation in Huntington's disease
Bamford, K. A., Caine, E. D., Kido, D. K., Plassche, W. M., & Shoulson, I. (1989) · Neurology · doi:10.1212/wnl.39.6.796 · Cited by 119
Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models
Phan, J., Hickey, M. A., Zhang, P., Chesselet, M.-F., & Reue, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn428 · Cited by 117
Strehlow, A. N. T., Li, J. Z., & Myers, R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl467 · Cited by 99
Rate and correlates of weight change in Huntington's disease
Hamilton, J. M., Wolfson, T., Peavy, G. M., Jacobson, M. W., & Corey-Bloom, J. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.017822 · Cited by 76
Abnormal morphology of peripheral cell tissues from patients with Huntington disease
Squitieri, F., Falleni, A., Cannella, M., Orobello, S., Fulceri, F., Lenzi, P., & Fornai, F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0328-4 · Cited by 70
Hypothesis: Huntingtin may function in membrane association and vesicular trafficking.
Truant, R., Atwal, R., & Burtnik, A. (2006) · Biochemistry and cell biology = Biochimie et biologie cellulaire · doi:10.1139/o06-181 · Cited by 59
Fukui, H., & Moraes, C. T. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm023 · Cited by 57
Mitochondrial matters of the brain: the role in Huntington’s disease
Turner, C., & Schapira, A. H. V. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9290-y · Cited by 53
Dierks, T., Linden, D. E. J., Hertel, A., Günther, T., Lanfermann, H., Niesen, A., Frölich, L., Zanella, F. E., Hör, G., Goebel, R., et al. (1998) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(98)00040-7 · Cited by 45
Gruñeiro‐Papendieck, L., Chiesa, A. E., Martínez, A. S., Heinrich, J. J., & Bergadá, C. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023286 · Cited by 42
Could successful (mitochondrial) networking help prevent Huntington's disease?
Oliveira, J. M. A., & Lightowlers, R. N. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000104 · Cited by 21
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306
Manczak, M., Calkins, M. J., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr139 · Cited by 827
Self-citationMitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
Disturbed mitochondrial dynamics and neurodegenerative disorders
Burté, F., Carelli, V., Chinnery, P. F., & Yu-Wai-Man, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 660
Mitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 602
Metadata
- Authors
- Shirendeb, U., Reddy, A. P., Manczak, M., Calkins, M. J., Mao, P., Tagle, D. A., & Hemachandra Reddy, P.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01-21
- Volume
- 20
- Issue
- 7
- Pages
- 1438-1455
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2171577843
- Cited by
- 409
- References
- 67
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.